Zions Bancorp ZION remains well-poised for growth driven by strong loans and deposits, higher interest rates and efforts to boost fee income. However, a mounting expense base and weak asset quality remain headwinds. Zions remains focused on its organic growth strategy. The company’s total revenues reflected a compound annual growth rate (CAGR) of 2.3% in the last five years ended 2023. This was primarily driven by robust loan growth, with loans and net leases (net of unearned income and fees) witnessing a 4.4% CAGR in the last four years ended 2023. While revenues dipped in the first quarter of 2024, decent loan demand, initiatives to boost fee income (majorly capital markets fees) and higher rates will likely aid the company’s top-line expansion. Amid the high interest rate scenario, Zions’ net interest margin (NIM) is expected to experience a modest expansion, while rising deposit costs will weigh on it to some degree. NIM increased to 3.06% in 2022 attributed to higher rates. Though NIM declined in 2023 and the first quarter of 2024 due to higher funding costs, the metric is expected to improve in the near term, given the stabilizing deposit costs, asset yield repricing and higher rates. Further, ZION’s capital distributions are encouraging. In 2022, the company announced an 8% increase in its quarterly dividend to 41 cents per share. Additionally, it has an existing share buyback plan. In February 2024, ZION authorized a share repurchase plan worth up to $35 million for the year. While Zions does not expect a significant amount of share buyback in the near term, the company is likely to sustain efficient capital distributions aided by a solid capital position and lower dividend payout ratio than its peers. ZION currently carries a Zacks Rank #3 (Hold). In the past three months, shares of the company have gained 3.5% compared with the industry’s growth of 2.7%. Zacks Investment Research Image Source: Zacks Investment Research Nevertheless, Zions has been witnessing a consistent rise in expenses. While total non-interest expenses decreased in 2020, the metric reflected a 4.5% CAGR in the last five years (2018-2023), primarily due to higher salary and employee benefit expenses. The uptrend persisted in the first quarter of 2024 as well. Distinctively, the company’s total technology expenditure was $483 million in 2023, which accounted for roughly 23% of total non-interest expenses. Amid its ongoing investments in franchise and digitizing operations, total expenses are expected to stay elevated in the near term. Also, ZION’s deteriorating asset quality remains a concern. A significant rise in provision for credit losses was witnessed in 2022 and 2023. Though the metric fell in the first quarter of 2024, the current tough macroeconomic backdrop will continue to exert pressure on the company’s asset quality, thus keeping the provision levels elevated in the near term. Banking Stocks Worth Considering Some better-ranked banking stocks worth a look at are Northrim BanCorp, Inc. NRIM and Bank of Marin Bancorp BMRC, each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks Rank #1 stocks here. The Zacks Consensus Estimate for NRIM’s current-year earnings has been revised 12.2% upward in the past 60 days. The company’s shares have risen 17.3% in the past six months. The Zacks Consensus Estimate for BMRC’s current-year earnings has been revised 4.8% upward in the past two months. The company’s shares have gained 6.1% in the past six months. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Zions Bancorporation, N.A. (ZION):Free Stock Analysis Report Northrim BanCorp Inc (NRIM):Free Stock Analysis Report Bank of Marin Bancorp (BMRC):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Zions' (ZION) Solid Loans and Deposits Aid Amid Rising Costs
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...